SCHEMBL21074872

SCHEMBL21074872

Cc1cc(=O)n(O)c(O)c1C(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.41
KMT2A Q03164 5/20 0.41
KDM4E B2RXH2 5/20 0.41
MAPT P10636 4/20 0.41
THRB P10828 2/20 0.41
ALDH1A1 P00352 2/20 0.40
MAPK1 P28482 2/20 0.40
LDHA P00338 2/20 0.35
LDHB P07195 2/20 0.35
IDH1 O75874 4/20 0.34
ALB P02768 3/20 0.33
BCL2 P10415 2/20 0.33
BCL2L1 Q07817 2/20 0.33
MCL1 Q07820 2/20 0.33
BCL2L2 Q92843 2/20 0.33
NPC1 O15118 1/20 0.31
USP2 O75604 1/20 0.31
LMNA P02545 1/20 0.31
ESR1 P03372 1/20 0.31
TP53 P04637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21074905 0.70 IDH1 (0.39) MEN1KMT2AKDM4EMAPTTHRB
SCHEMBL21045986 0.69 MEN1 (0.51) MEN1KMT2AKDM4EMAPTTHRB
SCHEMBL21074925 0.69 KDM4E (0.40) MEN1KMT2AKDM4EMAPTTHRB
SCHEMBL21937407 0.68 NOX4 (0.42) KDM4EMAPTALDH1A1LDHALDHB
SCHEMBL24070512 0.67 NQO2 (0.39) KDM4EMAPTALDH1A1LMNAPOLB
SCHEMBL5379461 0.65 CYP3A4 (0.48) MEN1KMT2AALDH1A1LDHALDHB
SCHEMBL11701184 0.65 BCL2 (0.45) MEN1KMT2AKDM4EMAPTTHRB
SCHEMBL11854311 0.64 IDH1 (0.37) MEN1KMT2AKDM4EMAPTTHRB
SCHEMBL7087619 0.64 IDH1 (0.46) IDH1NR1I2KDM4BCHRM1TBXA2R
SCHEMBL11315409 0.63 PDE3B (0.41) KDM4ELDHALDHBALBBCL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10550084-B2 Substituted 1-hydroxy-pyridin-2(1H)-ones, and methods of making and using same ARBUTUS BIOPHARMA CORPORATION (CA) 2020-02-04 US disclosed
US-20190169128-A1 SUBSTITUTED 1-HYDROXY-PYRIDIN-2(1H)-ONES, AND METHODS OF MAKING AND USING SAME ARBUTUS BIOPHARMA CORPORATION (CA) 2019-06-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10550084-B2 Substituted 1-hydroxy-pyridin-2(1H)-ones, and methods of making and using same RNASEH1, RNASE1, RNASEL MEN1 1891/4885KMT2A 1917/4885KDM4E 1030/4885
US-20190169128-A1 SUBSTITUTED 1-HYDROXY-PYRIDIN-2(1H)-ONES, AND METHODS OF MAKING AND USING SAME RNASEH1, RNASE1, RNASEL MEN1 1891/4885KMT2A 1917/4885KDM4E 1030/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.